Comparison of the effectiveness of integrated transdiagnostic therapy (UP) and acceptance and commitment therapy (ACT) on rumination, life satisfaction, treatment citizenship, emotional disorders, gastrointestinal symptoms and perceived stress in patients with irritable bowel syndrome (IBS)

Comparison of the effectiveness of integrated transdiagnostic therapy(UP) and acceptance and commitment therapy(ACT) on rumination, life satisfaction, treatment citizenship, emotional disorders, gastrointestinal symptoms and perceived stress in patients with irritable bowel syndrome(IBS)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211223053494N2

Enrollment

Registered

2022-06-27

Start date

2022-07-27

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group 1: includes patients with irritable bowel syndrome who receive integrated transdiagnostic treatment intervention in 10 sessions. The content of the first session inc

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having a diagnosis of irritable bowel syndrome Age over 18 years old Conscious satisfaction with conducting research Having at least a third grade of secondary education

Exclusion criteria

Exclusion criteria: Three consecutive absences in treatment sessions Reluctance to continue the treatment process Incompleteness of one of the questionnaires, in which case the rest of the questionnaires related to that person will be deleted

Design outcomes

Primary

Measure	Time frame
Score of Intensity of Gastrointestinal Symptoms in questionnaire (GSRS). Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Questionnaire of Intensity of Gastrointestinal Symptoms (GSRS).;Perceived Stress Score in Cohen Questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Cohen Perceived Stress Questionnaire.;Adherence of Medication Score in Morisky scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Morisky Medication Adherence Scale.;Life Satisfaction Score in Diener Questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Diener Life Satisfaction Questionnaire.;Rumination-Reflection Score in Nolen-Hoeksema and Morrow Scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Rumination-Reflection Scale.;Depression and Anxiety and Stress Score in Antony Scale DASS-21. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Depression and Anxiety and Stress Scale Antony (dass-21).	—

Measure

Time frame

Score of Intensity of Gastrointestinal Symptoms in questionnaire (GSRS). Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Questionnaire of Intensity of Gastrointestinal Symptoms (GSRS).;Perceived Stress Score in Cohen Questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Cohen Perceived Stress Questionnaire.;Adherence of Medication Score in Morisky scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Morisky Medication Adherence Scale.;Life Satisfaction Score in Diener Questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Diener Life Satisfaction Questionnaire.;Rumination-Reflection Score in Nolen-Hoeksema and Morrow Scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Rumination-Reflection Scale.;Depression and Anxiety and Stress Score in Antony Scale DASS-21. Timepoint: At the beginning of the study (before the intervention), after the intervention and 3and 6 months after the intervention. Method of measurement: Depression and Anxiety and Stress Scale Antony (dass-21).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirsam Kianimghadam

Shahid Beheshti University of Medical Sciences

as.kianimghadam@gmail.com+98 21 2303 1548

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026